BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26448945)

  • 1. Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival.
    Karapetsas A; Giannakakis A; Dangaj D; Lanitis E; Kynigopoulos S; Lambropoulou M; Tanyi JL; Galanis A; Kakolyris S; Trypsianis G; Coukos G; Sandaltzopoulos R
    Biomed Res Int; 2015; 2015():712438. PubMed ID: 26448945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of SMARCE1 is associated with CD8+ T-cell infiltration in early stage ovarian cancer.
    Giannakakis A; Karapetsas A; Dangaj D; Lanitis E; Tanyi J; Coukos G; Sandaltzopoulos R
    Int J Biochem Cell Biol; 2014 Aug; 53():389-98. PubMed ID: 24880093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The homeodomain transcription factor MEIS1 triggers chemokine expression and is involved in CD8+ T-lymphocyte infiltration in early stage ovarian cancer.
    Karapetsas A; Tokamani M; Evangelou C; Sandaltzopoulos R
    Mol Carcinog; 2018 Sep; 57(9):1251-1263. PubMed ID: 29802738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
    Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.
    Webb JR; Milne K; Watson P; Deleeuw RJ; Nelson BH
    Clin Cancer Res; 2014 Jan; 20(2):434-44. PubMed ID: 24190978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
    Borgoño CA; Kishi T; Scorilas A; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP
    Clin Cancer Res; 2006 Mar; 12(5):1487-93. PubMed ID: 16533772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells.
    Volkmann J; Reuning U; Rudelius M; Häfner N; Schuster T; Becker V Ros A; Weimer J; Hilpert F; Kiechle M; Dürst M; Arnold N; Schmalfeldt B; Meindl A; Ramser J
    Int J Cancer; 2013 Jun; 132(12):2820-32. PubMed ID: 23225306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
    Abiko K; Matsumura N; Hamanishi J; Horikawa N; Murakami R; Yamaguchi K; Yoshioka Y; Baba T; Konishi I; Mandai M
    Br J Cancer; 2015 Apr; 112(9):1501-9. PubMed ID: 25867264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High IGF2 expression is associated with poor clinical outcome in human ovarian cancer.
    Dong Y; Li J; Han F; Chen H; Zhao X; Qin Q; Shi R; Liu J
    Oncol Rep; 2015 Aug; 34(2):936-42. PubMed ID: 26063585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Growth-Related Oncogene-β Is Associated with Tumorigenesis, Metastasis, and Poor Prognosis in Ovarian Cancer.
    Ye Q; Zhai X; Wang W; Zhang S; Zhu H; Wang D; Wang C
    Dis Markers; 2015; 2015():387382. PubMed ID: 26063953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.
    Fialová A; Partlová S; Sojka L; Hromádková H; Brtnický T; Fučíková J; Kocián P; Rob L; Bartůňková J; Spíšek R
    Int J Cancer; 2013 Mar; 132(5):1070-9. PubMed ID: 22865582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration-inhibitory factor levels in serum of patients with ovarian cancer correlates with poor prognosis.
    Krockenberger M; Kranke P; Häusler S; Engel JB; Horn E; Nürnberger K; Wischhusen J; Dietl J; Hönig A
    Anticancer Res; 2012 Dec; 32(12):5233-8. PubMed ID: 23225421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
    Shigemasa K; Gu L; O'Brien TJ; Ohama K
    Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer.
    Webb JR; Milne K; Nelson BH
    Cancer Immunol Res; 2015 Aug; 3(8):926-35. PubMed ID: 25957117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.